Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Risk of vertebral fractures in hypoparathyroidism.

Formenti AM, Tecilazich F, Giubbini R, Giustina A.

Rev Endocr Metab Disord. 2019 Aug 30. doi: 10.1007/s11154-019-09507-x. [Epub ahead of print] Review.

PMID:
31471845
2.

Non-typhoidal Salmonella aortitis.

Gardini G, Zanotti P, Pucci A, Tomasoni L, Caligaris S, Paro B, Gavazzi E, Albano D, Bonardelli S, Maroldi R, Giubbini R, Castelli F.

Infection. 2019 Jul 18. doi: 10.1007/s15010-019-01344-z. [Epub ahead of print]

PMID:
31321641
3.

Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.

Albano D, Dondi F, Schumacher RF, D'Ippolito C, Porta F, Giubbini R, Bertagna F.

J Pediatr Hematol Oncol. 2019 May 22. doi: 10.1097/MPH.0000000000001518. [Epub ahead of print]

PMID:
31135716
4.

Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience.

Albano D, Ferro P, Bosio G, Fallanca F, Re A, Tucci A, Maria Ferreri AJ, Angelillo P, Gianolli L, Giubbini R, Bertagna F.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e457-e464. doi: 10.1016/j.clml.2019.04.016. Epub 2019 May 3.

PMID:
31129112
5.

Comparison of visual criteria for amyloid-PET reading: could their merging reduce the inter-raters variability?

Paghera B, Altomare D, Peli A, Morbelli S, Buschiazzo A, Bauckneht M, Giubbini R, Rodella C, Camoni L, Boccardi M, Festari C, Muscio C, Padovani A, Frisoni GB, Guerra UP.

Q J Nucl Med Mol Imaging. 2019 May 8. doi: 10.23736/S1824-4785.19.03124-8. [Epub ahead of print]

PMID:
31089074
6.

68Ga-PSMA PET thyroid incidentalomas.

Bertagna F, Albano D, Giovanella L, Bonacina M, Durmo R, Giubbini R, Treglia G.

Hormones (Athens). 2019 Jun;18(2):145-149. doi: 10.1007/s42000-019-00106-8. Epub 2019 Apr 15. Review.

PMID:
30989578
7.

18F-FDG PET/CT brown fat detection: Differences between adult and pediatric population in a 12 year experience.

Bonacina M, Albano D, Gazzilli M, Durmo R, Cerudelli E, Bosio G, Bertagna F, Giubbini R.

Rev Esp Med Nucl Imagen Mol. 2019 Jul - Aug;38(4):224-228. doi: 10.1016/j.remn.2019.01.006. Epub 2019 Apr 12. English, Spanish.

PMID:
30987886
8.

Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.

Durmo R, Albano D, Giubbini R.

Endocrine. 2019 May;64(2):424-425. doi: 10.1007/s12020-019-01916-x. Epub 2019 Apr 1. No abstract available.

PMID:
30937721
9.

Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.

Albano D, Bosio G, Bianchetti N, Pagani C, Re A, Tucci A, Giubbini R, Bertagna F.

Ann Nucl Med. 2019 Jul;33(7):449-458. doi: 10.1007/s12149-019-01354-9. Epub 2019 Mar 30.

PMID:
30929200
10.

Radioguided lung lesion localization: introducing a fluoroscopy system in a SPECT/CT scan.

Durmo R, Lechiara M, Benetti D, Rodella C, Camoni L, Albano D, Bertagna F, Giubbini R.

Nucl Med Commun. 2019 Jun;40(6):597-603. doi: 10.1097/MNM.0000000000000999.

PMID:
30789851
11.

Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma.

Albano D, Re A, Tucci A, Giubbini R, Bertagna F.

Ann Nucl Med. 2019 Apr;33(4):280-287. doi: 10.1007/s12149-019-01338-9. Epub 2019 Feb 20.

PMID:
30788775
12.

Encrusted cystitis detected by 18F-FDG PET/CT.

Bonacina M, Albano D, Durmo R, Barbera F, Bertagna F, Giubbini R.

Rev Esp Med Nucl Imagen Mol. 2019 Jul - Aug;38(4):250-251. doi: 10.1016/j.remn.2018.10.005. Epub 2019 Jan 9. English, Spanish. No abstract available.

PMID:
30638879
13.

F18-choline/C11-choline PET/CT thyroid incidentalomas.

Bertagna F, Albano D, Giovanella L, Giubbini R, Treglia G.

Endocrine. 2019 May;64(2):203-208. doi: 10.1007/s12020-019-01841-z. Epub 2019 Jan 12. Review.

PMID:
30637562
14.

18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer.

Albano D, Durmo R, Bertagna F, Giubbini R.

Endocrine. 2019 Mar;63(3):531-536. doi: 10.1007/s12020-018-01832-6. Epub 2018 Dec 29.

PMID:
30594973
15.

Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma.

Albano D, Zizioli V, Odicino F, Giubbini R, Bertagna F.

Rev Esp Med Nucl Imagen Mol. 2019 Mar - Apr;38(2):87-93. doi: 10.1016/j.remn.2018.09.005. Epub 2018 Dec 17. English, Spanish.

PMID:
30573388
16.

Treatment of hypoparathyroidism.

Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A.

Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):955-964. doi: 10.1016/j.beem.2018.12.002. Epub 2018 Dec 6. Review.

PMID:
30551988
17.

Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas.

Albano D, Zizioli V, Treglia G, Odicino F, Giubbini R, Bertagna F.

Rev Esp Med Nucl Imagen Mol. 2019 Jan - Feb;38(1):10-16. doi: 10.1016/j.remn.2018.04.006. Epub 2018 Nov 3. English, Spanish.

PMID:
30396849
18.

Prognostic role of baseline 18 F-FDG PET/CT parameters in MALT lymphoma.

Albano D, Bosio G, Camoni L, Farina M, Re A, Tucci A, Giubbini R, Bertagna F.

Hematol Oncol. 2019 Feb;37(1):39-46. doi: 10.1002/hon.2563. Epub 2018 Nov 8.

PMID:
30299563
19.

Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.

Albano D, Bosio G, Pagani C, Re A, Tucci A, Giubbini R, Bertagna F.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):87-96. doi: 10.1007/s00259-018-4173-2. Epub 2018 Oct 2.

PMID:
30276438
20.

Sub-endocardial and sub-epicardial measurement of myocardial blood flow using 13NH3 PET in man.

Sciagrà R, Milan E, Giubbini R, Kubik T, Di Dato R, Gallo L, Camoni L, Allocca M, Calabretta R.

J Nucl Cardiol. 2018 Sep 20. doi: 10.1007/s12350-018-1445-y. [Epub ahead of print]

PMID:
30238298
21.

Inter-reader variability of SPECT MPI readings in low- and middle-income countries: Results from the IAEA-MPI Audit Project (I-MAP).

Dondi M, Rodella C, Giubbini R, Camoni L, Karthikeyan G, Vitola JV, Einstein AJ, Arends BJ, Morozova O, Pascual TN, Paez D; I-MAP investigators.

J Nucl Cardiol. 2018 Aug 30. doi: 10.1007/s12350-018-1407-4. [Epub ahead of print]

PMID:
30168029
22.

Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.

Albano D, Panarotto MB, Durmo R, Rodella C, Bertagna F, Giubbini R.

Endocrine. 2019 Jan;63(1):79-86. doi: 10.1007/s12020-018-1713-2. Epub 2018 Aug 15.

PMID:
30112608
23.

Value of gated-SPECT MPI for ischemia-guided PCI of non-culprit vessels in STEMI patients with multivessel disease after primary PCI.

Phillips LM, Vitola JV, Shaw LJ, Giubbini R, Karthikeyan G, Alexanderson E, Dondi M, Paez D, Peix A.

J Nucl Cardiol. 2018 Oct;25(5):1616-1620. doi: 10.1007/s12350-018-1368-7. Epub 2018 Aug 1.

PMID:
30069820
24.

Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.

Albano D, Bertoli M, Battistotti M, Rodella C, Statuto M, Giubbini R, Bertagna F.

Ann Nucl Med. 2018 Oct;32(8):532-541. doi: 10.1007/s12149-018-1274-8. Epub 2018 Jul 7.

PMID:
29982990
25.

Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt's lymphoma: the role of Deauville and IHP criteria.

Albano D, Bosio G, Re A, Pagani C, Giubbini R, Bertagna F.

Leuk Lymphoma. 2019 Feb;60(2):326-333. doi: 10.1080/10428194.2018.1482541. Epub 2018 Jul 3.

PMID:
29966473
26.

Is physiology of coronary blood flow different in men and women?

Giubbini R, Albano D.

J Nucl Cardiol. 2018 Jun 19. doi: 10.1007/s12350-018-1346-0. [Epub ahead of print] No abstract available.

PMID:
29923101
27.

Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.

Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R.

Eur J Endocrinol. 2018 Sep;179(3):143-151. doi: 10.1530/EJE-18-0253. Epub 2018 Jun 13.

PMID:
29899030
28.

Different uptake of 123I-MIBG in the two main liver lobes: A persistant unsolved mistery.

Bonacina M, Albano D, Steimberg N, Bosio G, Camoni L, Bertagna F, Giubbini R, Mazzoleni G.

Rev Esp Med Nucl Imagen Mol. 2018 Sep - Oct;37(5):285-289. doi: 10.1016/j.remn.2018.01.004. Epub 2018 May 10. English, Spanish.

PMID:
29754941
29.

Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, Ceriani L, Prior JO, Giovanella L, Slart RHJA.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1945-1955. doi: 10.1007/s00259-018-4013-4. Epub 2018 Apr 23.

PMID:
29687207
30.

Ethmoidal and extranodal Burkitt lymphoma in a child with bilateral kidney Burkitt lymphoma lesions incidentally detected by 18F-FDG PET/CT.

Bonacina M, Bertoli M, Albano D, Bertagna F, Laffranchi F, Giubbini R.

Rev Esp Med Nucl Imagen Mol. 2018 Nov - Dec;37(6):384-386. doi: 10.1016/j.remn.2017.12.002. Epub 2018 Apr 7. English, Spanish. No abstract available.

PMID:
29636232
31.

18F-FDG PET/CT in splenic marginal zone lymphoma.

Albano D, Giubbini R, Bertagna F.

Abdom Radiol (NY). 2018 Oct;43(10):2721-2727. doi: 10.1007/s00261-018-1542-z.

PMID:
29500652
32.

Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct.

Peli A, Camoni L, Zilioli V, Durmo R, Bonacina M, Bertagna F, Paghera B, Giubbini R.

Nucl Med Commun. 2018 Apr;39(4):290-296. doi: 10.1097/MNM.0000000000000813.

PMID:
29360694
33.

18F-FDG PET/CT in primary brain lymphoma.

Albano D, Bosio G, Bertoli M, Giubbini R, Bertagna F.

J Neurooncol. 2018 Feb;136(3):577-583. doi: 10.1007/s11060-017-2686-3. Epub 2017 Nov 17.

PMID:
29147860
34.

High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma.

Mazziotti G, Formenti AM, Frara S, Olivetti R, Banfi G, Memo M, Maroldi R, Giubbini R, Giustina A.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):956-964. doi: 10.1210/jc.2017-01986.

PMID:
29121201
35.

Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.

Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R.

Endocrine. 2018 Jan;59(1):90-101. doi: 10.1007/s12020-017-1455-6. Epub 2017 Nov 6.

PMID:
29110129
36.

Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.

Lamartina L, Durante C, Lucisano G, Grani G, Bellantone R, Lombardi CP, Pontecorvi A, Arvat E, Felicetti F, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Crocetti U, Montesano T, Giubbini R, Orlandi F, Aimaretti G, Monzani F, Attard M, Francese C, Antonelli A, Limone P, Rossetto R, Fugazzola L, Meringolo D, Bruno R, Tumino S, Ceresini G, Centanni M, Monti S, Salvatore D, Spiazzi G, Mian C, Persani L, Barbaro D, Nicolucci A, Filetti S.

Thyroid. 2017 Dec;27(12):1490-1497. doi: 10.1089/thy.2017.0299. Epub 2017 Nov 10.

PMID:
29020892
37.

Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients.

Albano D, Borghesi A, Bosio G, Bertoli M, Maroldi R, Giubbini R, Bertagna F.

Br J Radiol. 2017 Nov;90(1079):20170311. doi: 10.1259/bjr.20170311. Epub 2017 Oct 3.

38.

18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.

Albano D, Bosio G, Treglia G, Giubbini R, Bertagna F.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):77-84. doi: 10.1007/s00259-017-3810-5. Epub 2017 Aug 19.

PMID:
28822997
39.

Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis.

Albano D, Bosio G, Giubbini R, Bertagna F.

Jpn J Radiol. 2017 Oct;35(10):574-583. doi: 10.1007/s11604-017-0668-1. Epub 2017 Jul 26.

PMID:
28748503
40.

Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.

Albano D, Bertagna F, Panarotto MB, Giubbini R.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26595. Epub 2017 Apr 24.

PMID:
28436606
41.

18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation.

Albano D, Bosio G, Giubbini R, Bertagna F.

Leuk Lymphoma. 2017 Oct;58(10):2328-2334. doi: 10.1080/10428194.2017.1298754. Epub 2017 Mar 7.

PMID:
28270020
42.

Comparison between the summed difference score and myocardial blood flow measured by 13N-ammonia.

Giubbini R, Peli A, Milan E, Sciagrà R, Camoni L, Albano D, Bertoli M, Bonacina M, Motta F, Statuto M, Rodella CA, De Agostini A, Calabretta R, Bertagna F; Italian Nuclear Cardiology Group (GICN).

J Nucl Cardiol. 2018 Oct;25(5):1621-1628. doi: 10.1007/s12350-017-0789-z. Epub 2017 Feb 3.

PMID:
28160262
43.

Is subclinical hyperthyroidism a real syndrome, different from overt hyperthyroidism?

Giubbini R, Peli A.

Endocrine. 2017 May;56(2):229-230. doi: 10.1007/s12020-016-1176-2. Epub 2016 Nov 14. No abstract available.

PMID:
27844210
44.

Left ventricular function during hyperemia: A dive into the unknown.

Giubbini R, Peli A.

J Nucl Cardiol. 2018 Jun;25(3):807-808. doi: 10.1007/s12350-016-0696-8. Epub 2016 Oct 13. No abstract available.

PMID:
27739038
45.

Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy.

Zilioli V, Peli A, Panarotto MB, Magri G, Alkraisheh A, Wiefels C, Rodella C, Giubbini R.

Endocrine. 2017 Jun;56(3):551-559. doi: 10.1007/s12020-016-1086-3. Epub 2016 Sep 29.

PMID:
27709475
46.

18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.

Albano D, Bertoli M, Ferro P, Fallanca F, Gianolli L, Picchio M, Giubbini R, Bertagna F.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):589-597. doi: 10.1007/s00259-016-3518-y. Epub 2016 Sep 12.

PMID:
27619357
47.

18F-FDG PET/CT and primary hepatic MALT: a case series.

Albano D, Giubbini R, Bertagna F.

Abdom Radiol (NY). 2016 Oct;41(10):1956-9. doi: 10.1007/s00261-016-0800-1.

PMID:
27259334
48.

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.

Bertagna F, Albano D, Bosio G, Piccardo A, Dib B, Giubbini R.

Curr Radiopharm. 2016;9(3):228-234. doi: 10.2174/1874471009666160523145005.

PMID:
27210819
49.

The dark side of the moon of coronary vasodilation.

Giubbini R, Bertagna F.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1491-2. doi: 10.1007/s00259-016-3416-3. No abstract available.

PMID:
27178273
50.

Impact of imaging protocol on left ventricular ejection fraction using gated-SPECT myocardial perfusion imaging.

Marcassa C, Giubbini R, Acampa W, Cittanti C, Djepaxhija O, Gimelli A, Kokomani A, Medolago G, Milan E, Sciagrà R.

J Nucl Cardiol. 2017 Aug;24(4):1292-1301. doi: 10.1007/s12350-016-0483-6. Epub 2016 Apr 6.

PMID:
27052809

Supplemental Content

Loading ...
Support Center